DocFind update helps Aetna members connect with surgeons trained in managing postsurgical pain using non-opioid medications PARSIPPANY, N.J. , June 15, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. today announced further collaboration with Aetna, one of the nation’s leading diversified
Aetna will reimburse for the use of EXPAREL in ambulatory surgical centers in Florida and New Jersey as part of a pilot program PARSIPPANY, N.J. , Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aetna has announced that they will reimburse select ambulatory surgical centers (ASCs) for the use of EXPAREL ®
Pacira grant will allow for the development and distribution of resources to educate patients and surgeons on opioid use in surgical care CHICAGO , Nov. 22, 2016 (GLOBE NEWSWIRE) -- The American College of Surgeons (ACS) today announced a new multifaceted initiative to improve the knowledge and
SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable Foundation, to advance the medical specialty of
SCHAUMBERG, Ill. and TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) today announced Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry Supporter Program to support the Society’s more than 56,000 physician anesthesiologist members to
Retrospective Study Published in Journal of Pain and Palliative Care Pharmacotherapy Utilized National Hospital Database and Assessed Nearly 320,000 Surgeries PARSIPPANY, N.J. --(BUSINESS WIRE)--Mar. 27, 2013-- Pacira Pharmaceuticals, Inc . (NASDAQ: PCRX) today announced data from a large-scale
PARSIPPANY, N.J. --(BUSINESS WIRE)--Jul. 15, 2015-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) announced today that Aratana Therapeutics, Inc. (NASDAQ: PETX) shared positive results from its pivotal field effectiveness study of AT-003, the company’s bupivacaine liposome injectable suspension
BOCA RATON, Fla. , Nov. 29, 2017 /PRNewswire/ -- Cancer Treatment Centers of America ® (CTCA), a national network of five hospitals, and Pacira Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on opioid alternatives, today announced a new collaboration dedicated to reducing the
-- Product-specific C-code for ambulatory surgical center procedures and D-code for dental procedures to take effect January 1 , 2019 -- -- Important reimbursement milestone that will expand patient access to non-opioid strategies for postsurgical pain -- PARSIPPANY, N.J. , Nov.
PARSIPPANY, N.J. , Nov. 10, 2016 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that senior leadership is scheduled to present an overview of the company at the following investor conferences in November: Jefferies 2016 London Healthcare Conference at 2:00 p.m.